Choline Bitartrate
Click to View Image
C9H19NO7 253.25
2-Hydroxyethanaminium,-N,N,N-trimethyl-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1).
(2-Hydroxyethyl)trimethylammonium-l-(+)-tartrate salt (1:1) [87-67-2].
» Choline Bitartrate contains not less than 99.0 percent and not more than 100.5 percent of C9H19NO7, calculated on the anhydrous basis.
Packaging and storage— Preserve in well-closed containers.
USP Reference standards 11
USP Choline Bitartrate RS.
USP Choline Chloride RS
.
Identification—
B: Dissolve 1 g of Choline Bitartrate with 20 mL of water, and add 2 mL of potassium chloride solution (1 in 4). A white precipitate of potassium bitartrate is formed.
Specific rotation 781S: between +17.5 and +18.5.
Test solution: 400 mg per mL, in water.
pH 791: between 3.0 and 4.0, in a solution (1 in 10).
Water, Method I 921: not more than 0.5%.
Residue on ignition 281: not more than 0.1%.
Arsenic, Method I 211 Proceed as directed in the test for Arsenic under Choline Chloride: the limit is 2 µg per g.
Lead 251 Proceed as directed in the test for Lead under Choline Chloride: not more than 0.3 µg per g is found.
Limit of total amines— Proceed as directed in the test for Limit of total amines under Choline Chloride: not more than 10 µg per g.
Test solution— Transfer 10.0 g of Choline Bitartrate to a beaker containing a plastic-coated stirring bar, add 70 mL of sodium hydroxide TS and 130 mL of water, and stir until dissolved.
Chromatographic purity—
Buffer solution, Mobile phase, Standard solution, and Chromatographic system— Proceed as directed in the test for Chromatographic purity under Choline Chloride.
Test solution— Transfer about 500 mg of Choline Bitartrate, accurately weighed, to a centrifuge tube; add 2.0 mL of water; and swirl to dissolve. Add 0.5 mL of potassium chloride solution (7.5 in 25), centrifuge, and transfer 1.0 mL of the supernatant to a 24-mL screw-capped vial. Dry at 120 for 2 hours. Add 400 mg of 3,5-dinitrobenzoyl chloride and 10 mL of acetonitrile, and mix. Cap the vial, and heat at 55 for 2 hours. Cool to room temperature, add 5 mL of water, and allow to stand for 5 minutes. Quantitatively transfer this solution to a 50-mL volumetric flask, dilute with Mobile phase to volume, and mix. Pipet 2.0 mL of the solution to a 25-mL volumetric flask, dilute with Mobile phase to volume, and mix.
Procedure— Separately inject equal volumes (about 20 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure all the peak responses. Calculate the percentage of each impurity in the portion of Choline Bitartrate taken by the formula:
(253.25/139.62)62,500(C/W)(ri / rS)
in which 253.25 and 139.62 are the molecular weights of choline bitartrate and choline chloride, respectively; C is the concentration of USP Choline Chloride RS, in mg per mL, in the Standard solution; W is the weight, in mg, of Choline Bitartrate taken to prepare the Test solution; ri is the peak response for each impurity, other than that of the choline bitartrate derivative and 3,5-dinitrobenzoic acid; and rS is the peak response for the choline chloride derivative in the Standard solution: not more than 0.3% of any individual impurity is found; and not more than 2.0% of total impurities is found.
Residual solvents 467: meets the requirements, except that the limit for 1,4-dioxane is 10 µg per g.
Assay— Transfer about 200 mg of Choline Bitartrate, accurately weighed, to a conical flask, and dissolve with 50 mL of glacial acetic acid. Titrate with 0.1 N perchloric acid VS, determining the endpoint potentiometrically (see Titrimetry 541). Perform a blank determination, and make any necessary correction. Each mL of 0.1 N perchloric acid is equivalent to 25.32 mg of C9H19NO7.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Curtis Phinney

1-301-816-8540
(DSN05) Dietary Supplements - Non-Botanicals
Reference Standards Lili Wang, Technical Services Scientist
1-301-816-8129
RSTech@usp.org
USP32–NF27 Page 978
Pharmacopeial Forum: Volume No. 30(3) Page 950